Followers | 43 |
Posts | 4309 |
Boards Moderated | 0 |
Alias Born | 07/14/2010 |

Monday, October 02, 2023 12:39:38 PM
Recent GPCR News
- Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences • GlobeNewswire Inc. • 05/29/2025 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2025 08:30:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2025 08:21:42 PM
- Structure Therapeutics Reports First Quarter 2025 Financial Results and Recent Highlights • GlobeNewswire Inc. • 05/08/2025 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/24/2025 08:35:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2025 08:30:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2025 12:45:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2025 12:45:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2025 12:45:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2025 12:45:07 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2025 10:24:52 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2025 09:43:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2025 09:38:46 PM
- Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights • GlobeNewswire Inc. • 02/27/2025 09:05:00 PM
- Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences • GlobeNewswire Inc. • 01/30/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 09:16:05 PM
- Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity • GlobeNewswire Inc. • 12/17/2024 09:01:00 PM
- Structure Therapeutics to Participate in the Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/15/2024 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 09:16:55 PM
- Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights • GlobeNewswire Inc. • 11/13/2024 09:05:00 PM
- Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity • GlobeNewswire Inc. • 11/13/2024 09:01:00 PM
- Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024 • GlobeNewswire Inc. • 10/31/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 09:42:38 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 09:41:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:15:11 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM
ECGI Holdings Invests in AI-Powered Fantasy Sports Startup Payday Fantasy • ECGI • Jun 10, 2025 8:30 AM
Avant Technologies Signs Letter of Intent for a Business Combination • AVAI • Jun 10, 2025 8:00 AM